1. Ifosfamide‐induced encephalopathy: Brand‐name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®). (4th March 2019) Authors: Chambord, Jeremy; Henny, Fabien; Salleron, Julia; Hombourger, Benoit; Lider, Pauline; Vigneron, Jean; Demore, Beatrice; Vallance, Catherine; Rios, Maria Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 44:Number 3(2019) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The nocebo effect: a clinical challenge in the era of biosimilars. (2nd September 2018) Authors: Pouillon, Lieven; Socha, Marie; Demore, Beatrice; Thilly, Nathalie; Abitbol, Vered; Danese, Silvio; Peyrin-Biroulet, Laurent Journal: Expert review of clinical immunology Issue: Volume 14:Number 9(2018) Page Start: 739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗